ArticleBMC urology2019

A retrospective feasibility study of biweekly docetaxel in patients with high-risk metastatic castration-naïve prostate cancer.

Sang Eun Yoon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.